Company Info
Phone(484) 581-7505
Year Established
2004
Ticker
ZYNE
Exchange
NASDAQ
Contacts
Jim FickenscherCFO & VP, Corporate Development
Armando Anido
Chair & CEO
Terri B. Sebree
President
Donna L. Gutterman, PharmD
VP, Medical
Albert P. Parker
CLO
Ray Mannion
VP, Manufacturing
Company Description
Zynerba Pharmaceuticals is the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.
